Gribonika I, Band V, Chi L, Perez-Chaparro P, Link V, Ansaldo E
Nature. 2024; 638(8052):1043-1053.
PMID: 39662506
PMC: 11864984.
DOI: 10.1038/s41586-024-08376-y.
Bento L, Bacal N, Marti L
Einstein (Sao Paulo). 2024; 22:eRW1042.
PMID: 39630753
PMC: 11634355.
DOI: 10.31744/einstein_journal/2024RW1042.
Shu D, Sidiropoulos D
Methods Mol Biol. 2024; 2864:43-55.
PMID: 39527216
DOI: 10.1007/978-1-0716-4184-2_3.
Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z
Signal Transduct Target Ther. 2024; 9(1):225.
PMID: 39198425
PMC: 11358547.
DOI: 10.1038/s41392-024-01947-5.
Chu X, Li X, Zhang Y, Dang G, Miao Y, Xu W
Nat Cancer. 2024; 5(9):1409-1426.
PMID: 39147986
DOI: 10.1038/s43018-024-00807-z.
Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma.
Xu W, Lu J, Tian X, Ye S, Wei S, Wang J
MedComm (2020). 2024; 5(1):e461.
PMID: 38222314
PMC: 10784869.
DOI: 10.1002/mco2.461.
The roles of tertiary lymphoid structures in chronic diseases.
Sato Y, Silina K, van den Broek M, Hirahara K, Yanagita M
Nat Rev Nephrol. 2023; 19(8):525-537.
PMID: 37046081
PMC: 10092939.
DOI: 10.1038/s41581-023-00706-z.
Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.
Chen J, Chen J, Wang L
J Zhejiang Univ Sci B. 2022; 23(10):812-822.
PMID: 36226536
PMC: 9561406.
DOI: 10.1631/jzus.B2200174.
Chronic stress induces colonic tertiary lymphoid organ formation and protection against secondary injury through IL-23/IL-22 signaling.
Gomez-Nguyen A, Gupta N, Sanaka H, Gruszka D, Pizarro A, DiMartino L
Proc Natl Acad Sci U S A. 2022; 119(40):e2208160119.
PMID: 36161939
PMC: 9546604.
DOI: 10.1073/pnas.2208160119.
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction.
Nayar S, Pontarini E, Campos J, Berardicurti O, Smith C, Asam S
Commun Biol. 2022; 5(1):413.
PMID: 35508704
PMC: 9068764.
DOI: 10.1038/s42003-022-03344-6.
The spatial transcriptomic landscape of the healing mouse intestine following damage.
Parigi S, Larsson L, Das S, Ramirez Flores R, Frede A, Tripathi K
Nat Commun. 2022; 13(1):828.
PMID: 35149721
PMC: 8837647.
DOI: 10.1038/s41467-022-28497-0.
Ileitis-associated tertiary lymphoid organs arise at lymphatic valves and impede mesenteric lymph flow in response to tumor necrosis factor.
Czepielewski R, Erlich E, Onufer E, Young S, Saunders B, Han Y
Immunity. 2021; 54(12):2795-2811.e9.
PMID: 34788601
PMC: 8678349.
DOI: 10.1016/j.immuni.2021.10.003.
Insights Into Unveiling a Potential Role of Tertiary Lymphoid Structures in Metastasis.
Mustapha R, Ng K, Monypenny J, Ng T
Front Mol Biosci. 2021; 8:661516.
PMID: 34568423
PMC: 8455920.
DOI: 10.3389/fmolb.2021.661516.
Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies.
Kang W, Feng Z, Luo J, He Z, Liu J, Wu J
Front Immunol. 2021; 12:689270.
PMID: 34394083
PMC: 8358404.
DOI: 10.3389/fimmu.2021.689270.
Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts.
Rodriguez A, Peske J, Woods A, Leick K, Mauldin I, Meneveau M
Cell Rep. 2021; 36(3):109422.
PMID: 34289373
PMC: 8362934.
DOI: 10.1016/j.celrep.2021.109422.
TRIMs: selective recruitment at different steps of the NF-κB pathway-determinant of activation or resolution of inflammation.
Roy M, Singh R
Cell Mol Life Sci. 2021; 78(17-18):6069-6086.
PMID: 34283248
PMC: 11072854.
DOI: 10.1007/s00018-021-03900-z.
Alternative pathways for the development of lymphoid structures in humans.
Berteloot L, Molina T, Bruneau J, Picard C, Barlogis V, Secq V
Proc Natl Acad Sci U S A. 2021; 118(29).
PMID: 34261794
PMC: 8307690.
DOI: 10.1073/pnas.2108082118.
Therapeutic Induction of Tertiary Lymphoid Structures in Cancer Through Stromal Remodeling.
Johansson-Percival A, Ganss R
Front Immunol. 2021; 12:674375.
PMID: 34122434
PMC: 8191417.
DOI: 10.3389/fimmu.2021.674375.
Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.
N J, J T, Sl N, Gt B
Oncoimmunology. 2021; 10(1):1900508.
PMID: 33854820
PMC: 8018489.
DOI: 10.1080/2162402X.2021.1900508.
STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment.
Chelvanambi M, Fecek R, Taylor J, Storkus W
J Immunother Cancer. 2021; 9(2).
PMID: 33526609
PMC: 7852948.
DOI: 10.1136/jitc-2020-001906.